Hatzerim-based Picodya develops an in vitro diagnostics (IVD) platform named B-MatrixTM and is valued at between $80 and $100 million
As published on Calcalist by Golan Hazani on November 8, 2020
Read the full story: Calcalist
Picodya Raises $10 Million for Rapid Diagnostics Innovation
